Thank you Dr Robert Foster, Dr Adam Wood and Dr Natalie Burden for excellent talks and subsequent discussion on #NAMs and #insilico paths to chemical safety assessment!
#BTSLiverpool2024 #toxicology
Lhasa Limited Unilever The National Centre for the 3Rs
Prof Marco Viceconti recently met the officers of the French Agence de l'Innovation en Sante, providing them with more information on #InSilicoTrials , & on the barriers that are still slowing down the adoption of #insilico methodologies.
Save the date for their next event!
👇
🚀 Discover next-gen #cardiaccare at the SimCardioTest, EU project on e-health -@eHealth_EU Event | May 30-31 | PariSanté
Explore #insilico trials & the innovative platform developed within the project. Learn about tools enhancing #medicalproduct development and #drugsafety .
✍️ Register: lnkd.in/dsvrPRE7
Zurich Med Tech's Sim4Life software V8.0 is now compatible on web & desktop. The software makes use of the o²S²PARC platform. Learn more on the SPARC Portal: bit.ly/4aA9qKG #NIH_SPARC #opendata #modeling #simulations #insilico #computational #lifesciences #onlineplatform
A new week, a new #AI -enabled #DrugDevelopment story and yeah, Insilico Medicine is in the mix. #CancerResearch #cancers #HealthcareInnovation #aiforgood firstwordpharma.com/story/5846699/
🌐🩺 CEO Alex Zhavoronkov (Alex Zhavoronkov, PhD (aka Aleksandrs Zavoronkovs)) of Insilico Medicine, a biotech firm pioneering AI-driven drug discovery, is speaking at the Future Health Summit during Abu Dhabi Global Healthcare Week. Insilico, having raised $400M, is advancing 11 preclinical candidates and commenced
JUST IN: Insilico Medicine's AI breakthrough unveils new Polθ inhibitors for BRCA-associated cancers, offering promising treatment options for TNBC and ovarian cancers. Published in Bioorganic & Medicinal Chemistry. #InsilicoMedicine #AI #cancerresearch
#VirtualEvent April 25th, 2024: #InSilico #Simulation for #Medtech and #Biopharma - ift.tt/ljqGhNS instagr.am/p/C53h6abM5Zo/